Indivior Pharmaceuticals Inc (INDV) एक सार्वजनिक रूप से कारोबार करने वाली कंपनी है में स्वास्थ्य सेवा क्षेत्र, संचालन करती है Drug Manufacturers - Specialty & Generic उद्योग. कंपनी का मुख्यालय है North Chesterfield, VA, United States. वर्तमान CEO हैं Joseph J. Ciaffoni.
INDV के पास है IPO तिथि 2014-12-29, 1,030 पूर्णकालिक कर्मचारी, पर सूचीबद्ध NASDAQ Global Select, बाजार पूंजीकरण $4.06B.
Indivior PLC is a specialty pharmaceutical company focused on developing and commercializing prescription medications for substance use disorders, serious mental illnesses, and opioid overdose. The company's marketed portfolio includes SUBLOCADE and SUBUTEX PRO, buprenorphine extended-release monthly injections; SUBOXONE sublingual films and tablets; SUBUTEX sublingual tablets; OPVEE nasal spray for opioid overdose reversal; and PERSERIS for schizophrenia treatment. Indivior maintains a robust pipeline with multiple clinical and preclinical programs, including INDV-2000 for opioid use disorder, INDV-1000 for alcohol use disorder, and several collaborative development programs addressing opioid, cannabis, and other substance use disorders. Headquartered in North Chesterfield, Virginia, the company operates across the United States, United Kingdom, and international markets.
